Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/hae.14309 | DOI Listing |
Res Pract Thromb Haemost
November 2024
Children's Hospital of Central Switzerland, Luzern, Switzerland.
Background: Recurrent hemarthrosis and resultant hemophilic arthropathy are significant causes of morbidity in persons with hemophilia, despite the marked evolution of hemophilia care. Prevention, timely diagnosis, and treatment of bleeding episodes are key. However, a physical examination or a patient's assessment of musculoskeletal pain may not accurately identify a joint bleed.
View Article and Find Full Text PDFSemin Thromb Hemost
November 2024
Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantua, Italy.
Historically, the aim of treatment for hemophilia, the congenital X-linked hemorrhagic disorder due to deficiencies of coagulation Factor (F) VIII (hemophilia A) or FIX (hemophilia B), has been the replacement through factor concentrates, whose regular administration (i.e., prophylaxis) has been shown to be highly effective in preventing bleeding complications and it is currently considered the gold standard of hemophilia treatment.
View Article and Find Full Text PDFPLoS One
October 2024
Department of Gastroenterology, Hepatology, Infection Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
Alu-elements comprise a large part of the human genome and some insertions have been shown to cause diseases. Here, we illuminate the protective role of an Alu-element in the 3'UTR of the human Factor 9 gene and its ability to ameliorate a poly(A) site mutation in a hemophilia B patient, preventing him from developing a severe disease. Using a minigene, we examined the disease-causing mutation and the modifying effect of the transposon in cellulo.
View Article and Find Full Text PDFGlob Pediatr Health
October 2024
Ibn Sina University Hospital Center, Rabat, Morocco.
Haemophilia
November 2024
Orthopedics and Traumatology Clinic, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Introduction: The term 'chronic inflammatory arthritis' (IA) can be used to define a group of heterogeneous diseases in which inflammation of the synovium is the common feature while having different pathogenesis and clinical outcomes. This condition can be found in osteoarthritis (OA), rheumatoid arthritis (RA), and hemophilic arthropathy (HA).
Aim: The objective is to try to highlight similarities and differences in the three pathological conditions and understand both molecular and physiological mechanisms.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!